• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带 miR-301b-3p 抑制剂的 RNA 纳米颗粒的制备、表征及体外抑癌功能。

Preparation, characterisation, and in vitro cancer-suppression function of RNA nanoparticles carrying miR-301b-3p Inhibitor.

机构信息

Department of Cardiothoracic Surgery, Affiliated Hospital of Jiaxing University (the First Hospital of Jiaxing), Jiaxing, Zhejiang, China.

出版信息

IET Nanobiotechnol. 2023 May;17(3):224-233. doi: 10.1049/nbt2.12120. Epub 2023 Mar 9.

DOI:10.1049/nbt2.12120
PMID:36892102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10190642/
Abstract

BACKGROUND

Multidrug resistance is the biggest barrier on the way to chemotherapy for lung adenocarcinoma (LUAD). For some LUAD patients with cisplatin (DDP) resistance and poor prognoses, the authors put forward RNA nanoparticles (NPs) carrying miR-301b-3p Inhibitor.

METHODS

The NPs were composed of miR-301b-3p, A549 aptamer (A549apt), and Cyanine 5 in a bottom-up manner with a 3-way-junction (3WJ) structure. Diameter, assembly process, and morphology of NPs were observed by Dynamic Light Scattering, Native-Polyacrylamide Gel Electrophoresis, and Atomic Force Microscopy. Cell internalisation, toxicity, proliferation, migration, invasion, and apoptosis were assayed by confocal laser scanning microscope, CCK8, colony formation assay, Transwell, western blot, and flow cytometry.

RESULTS

3WJ-apt-miR was evenly distributed, with diameter of 19.61 ± 0.49 nm and triangular branching structures. The accurate delivery of this NP in vivo was ensured by A549 aptamer featuring specific targeting, with smaller side effects than traditional chemotherapy. Such nanomaterials were effectively internalized by cancer cells, with normal cell activity intact. Cancer cell proliferation, invasion, and migration were suppressed, and DDP sensitivity was enhanced, causing DNA damage and facilitating apoptosis of DDP-resistant cells.

CONCLUSION

Based on RNA self-assembling, the authors researched the effect of miRNA on DDP sensitivity in LUAD regarding gene regulation. 3WJ-apt-miR paves the way for clinical tumour therapy.

摘要

背景

多药耐药性是肺腺癌 (LUAD) 化疗的最大障碍。对于一些顺铂 (DDP) 耐药且预后不良的 LUAD 患者,作者提出了携带 miR-301b-3p 抑制剂的 RNA 纳米颗粒 (NPs)。

方法

NPs 采用自上而下的方法,由 miR-301b-3p、A549 适体 (A549apt) 和 Cy5 组成,具有 3 向结 (3WJ) 结构。通过动态光散射、天然聚丙烯酰胺凝胶电泳和原子力显微镜观察 NPs 的直径、组装过程和形态。通过共聚焦激光扫描显微镜、CCK8、集落形成实验、Transwell、western blot 和流式细胞术检测细胞内化、毒性、增殖、迁移、侵袭和凋亡。

结果

3WJ-apt-miR 均匀分布,直径为 19.61 ± 0.49nm,具有三角形分支结构。A549 适体具有特异性靶向作用,确保了这种 NP 的体内精确传递,副作用小于传统化疗。这种纳米材料被癌细胞有效内化,正常细胞活性完好无损。癌细胞增殖、侵袭和迁移受到抑制,DDP 敏感性增强,导致 DNA 损伤,促进 DDP 耐药细胞凋亡。

结论

基于 RNA 自组装,作者研究了 miRNA 对 LUAD 中基因调控下 DDP 敏感性的影响。3WJ-apt-miR 为临床肿瘤治疗铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/479b27a21af0/NBT2-17-224-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/8a4a5253f509/NBT2-17-224-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/0ac0c19cde1a/NBT2-17-224-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/a7473bbb4128/NBT2-17-224-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/66ce92e34256/NBT2-17-224-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/479b27a21af0/NBT2-17-224-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/8a4a5253f509/NBT2-17-224-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/0ac0c19cde1a/NBT2-17-224-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/a7473bbb4128/NBT2-17-224-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/66ce92e34256/NBT2-17-224-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d9/10190642/479b27a21af0/NBT2-17-224-g002.jpg

相似文献

1
Preparation, characterisation, and in vitro cancer-suppression function of RNA nanoparticles carrying miR-301b-3p Inhibitor.携带 miR-301b-3p 抑制剂的 RNA 纳米颗粒的制备、表征及体外抑癌功能。
IET Nanobiotechnol. 2023 May;17(3):224-233. doi: 10.1049/nbt2.12120. Epub 2023 Mar 9.
2
Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.环状 RNA circ_0058357 通过 miR-361-3p/ABCC1 轴调控顺铂耐药非小细胞肺癌细胞。
Thorac Cancer. 2021 Nov;12(21):2894-2906. doi: 10.1111/1759-7714.14150. Epub 2021 Sep 14.
3
Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.抑制微小RNA-196a可能会逆转A549/DDP非小细胞肺癌细胞系的顺铂耐药性。
Tumour Biol. 2016 Feb;37(2):2387-94. doi: 10.1007/s13277-015-4017-7. Epub 2015 Sep 16.
4
circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.circ_0007385 作为竞争性内源性 RNA,与 miR-519d-3p 结合,抑制非小细胞肺癌细胞的恶性行为和顺铂耐药性。
Thorac Cancer. 2020 Aug;11(8):2196-2208. doi: 10.1111/1759-7714.13527. Epub 2020 Jun 29.
5
Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.Linc00173 的下调通过 miR-1275/PROCA1/ZFP36L2 轴增加 BCL2 mRNA 的稳定性,并诱导肺腺癌获得顺铂耐药性。
J Exp Clin Cancer Res. 2023 Jan 10;42(1):12. doi: 10.1186/s13046-022-02560-6.
6
MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.miR-200c-3p 和 miR-485-5p 的过表达通过靶向 RRM2 提高顺铂敏感性并抑制非小细胞肺癌细胞的恶性表型。
Thorac Cancer. 2022 Jul;13(13):1974-1985. doi: 10.1111/1759-7714.14475. Epub 2022 May 22.
7
The malignant property of circHIPK2 for angiogenesis and chemoresistance in non-small cell lung cancer.环状 RNA HIPK2 通过促进血管生成和化疗耐药性促进非小细胞肺癌的恶性进展。
Exp Cell Res. 2022 Oct 15;419(2):113276. doi: 10.1016/j.yexcr.2022.113276. Epub 2022 Jul 19.
8
Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).Circ_0020123 通过海绵吸附 miR-140-3p 调控同源盒 B5(HOXB5)从而部分增强非小细胞肺癌细胞对顺铂的耐药性。
Bioengineered. 2022 Mar;13(3):5126-5140. doi: 10.1080/21655979.2022.2036910.
9
MIR-301b-3p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting DLC1.MIR-301b-3p 通过靶向 DLC1 促进肺腺癌细胞的增殖、迁移和侵袭。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821990036. doi: 10.1177/1533033821990036.
10
miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.miR-324-3p 通过诱导 GPX4 介导的铁死亡逆转肺腺癌细胞系 A549 中的顺铂耐药性。
Biochem Biophys Res Commun. 2021 Apr 16;549:54-60. doi: 10.1016/j.bbrc.2021.02.077. Epub 2021 Mar 1.

引用本文的文献

1
Aptamer-ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy.适体-寡核苷酸嵌合体:实现细胞特异性寡核苷酸靶向治疗。
Cells. 2025 May 12;14(10):697. doi: 10.3390/cells14100697.
2
An Overview of Supramolecular Platforms Boosting Drug Delivery.促进药物递送的超分子平台概述
Bioinorg Chem Appl. 2023 Nov 13;2023:8608428. doi: 10.1155/2023/8608428. eCollection 2023.

本文引用的文献

1
The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development.RNA 纳米颗粒的动态、运动和变形特性促进了药物开发的第三个里程碑。
Adv Drug Deliv Rev. 2022 Jul;186:114316. doi: 10.1016/j.addr.2022.114316. Epub 2022 May 5.
2
microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells.间充质干细胞来源的细胞外囊泡中的 microRNA-301b-3p 通过抑制 TXNIP 促进胃癌多药耐药。
Cell Biol Toxicol. 2023 Oct;39(5):1923-1937. doi: 10.1007/s10565-021-09675-0. Epub 2022 Mar 4.
3
Cancer statistics, 2022.
癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
4
Research on Mechanism of miR-214 Packaged with Lipidosome Nanoparticles on Prompting the Apoptosis of Intestinal Cancer Through Regulating p53 Pathway.载脂体纳米颗粒包裹 miR-214 通过调控 p53 通路促进肠癌细胞凋亡的机制研究。
J Biomed Nanotechnol. 2021 Dec 1;17(12):2391-2398. doi: 10.1166/jbn.2021.3212.
5
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling.肺腺癌的全外显子测序、拷贝数分析和基因表达谱相结合的分子特征分析。
Expert Rev Mol Diagn. 2022 Jan;22(1):77-100. doi: 10.1080/14737159.2022.2017774. Epub 2021 Dec 22.
6
Molecular Tumor Board Review and Improved Overall Survival in Non-Small-Cell Lung Cancer.分子肿瘤委员会审查与非小细胞肺癌患者总体生存改善。
JCO Precis Oncol. 2021 Sep 29;5. doi: 10.1200/PO.21.00210. eCollection 2021.
7
LINC01089, suppressed by YY1, inhibits lung cancer progression by targeting miR-301b-3p/HPDG axis.LINC01089 通过靶向 miR-301b-3p/HPDG 轴抑制 YY1 抑制肺癌的进展。
Cell Biol Toxicol. 2022 Dec;38(6):1063-1077. doi: 10.1007/s10565-021-09643-8. Epub 2021 Sep 24.
8
Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy.早期和局部晚期非小细胞肺癌:聚焦诊断、分期、全身及局部治疗的ESMO临床实践指南更新
Ann Oncol. 2021 Dec;32(12):1637-1642. doi: 10.1016/j.annonc.2021.08.1994. Epub 2021 Sep 1.
9
Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020.中国癌症发病率、死亡率和疾病负担的变化趋势分析:基于 2020 年全球公布的流行病学数据与美国和英国的比较
Cancer Commun (Lond). 2021 Oct;41(10):1037-1048. doi: 10.1002/cac2.12197. Epub 2021 Jul 20.
10
LINC01089 suppresses lung adenocarcinoma cell proliferation and migration via miR-301b-3p/STARD13 axis.LINC01089 通过 miR-301b-3p/STARD13 轴抑制肺腺癌细胞增殖和迁移。
BMC Pulm Med. 2021 Jul 19;21(1):242. doi: 10.1186/s12890-021-01568-6.